Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Common Shares Outstanding
|
Sonoma Pharmaceuticals Inc
Common Shares Outstanding Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Common Shares Outstanding
$13.7m
|
CAGR 3-Years
87%
|
CAGR 5-Years
59%
|
CAGR 10-Years
56%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Shares Outstanding
$2.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Shares Outstanding
$2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Pfizer Inc
NYSE:PFE
|
Common Shares Outstanding
$5.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Common Shares Outstanding
$2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Shares Outstanding
$950.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Sonoma Pharmaceuticals Inc's Common Shares Outstanding?
Common Shares Outstanding
13.7m
USD
13.7m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Common Shares Outstanding amounts to 13.7m USD.
What is Sonoma Pharmaceuticals Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
56%
56%
Over the last year, the Common Shares Outstanding growth was 340%. The average annual Common Shares Outstanding growth rates for Sonoma Pharmaceuticals Inc have been 87% over the past three years , 59% over the past five years , and 56% over the past ten years .
You don't have any saved screeners yet
